Residency Listing

Children's Minnesota
2525 Chicago Ave S; 17-700
Minneapolis, MN 55404
Code: 63046
NMS Code: 790470
Postgraduate Year Two (PGY2)
Clinical Pharmacogenomics
Accreditation Status: Pre-candidate
Residency Program Director: David Gregornik, BS, Pharm.D.
(612) 813-8626
Fax: (612) 813-6360
Director of Pharmacy: Nancy Mendelsohn, MD
(612) 813-7240
Fax: (612) 813-6360
Residency Information:
Duration/Type: 12 Months
Number of Positions: 1
Application Deadline: 2019-01-07
Starting Date: 2019-07-01
Estimated Stipend: 50000
Interview Required: Yes
Residency Special Features:   The PGY2 residency in Clinical Pharmacogenomics is designed to provide the resident with the knowledge and skills necessary to implement a new Clinical Pharmacogenomics service.  The resident will join a Medical Genetics and Genomics Program made up of a pharmacist, medical geneticists, genetic counselors, clinical investigators, database manager and clinical informatics specialists dedicated to implementation of clinical pharmacogenomics in pediatric primary and specialty care.  The resident will assist the Pharmacogenomics Program Director in managing the program.
Fringe Benefits:   Includes 30 days PTO (vacation/holiday/sick), health & dental insurance and professional travel reimbursement.  PALS certification/teaching certificate opportunities available.
Special Requirements for Acceptance:   PharmD, PGY1 residency, eligibility for MN licensure, CV, three reference letters, academic transcripts, US citizen or green card/F1 visa, PhORCAS application.
Training Site Type: Hospital/Ambulatory Care
Owner Affiliate: Private
Model Type(s): Teaching, Tertiary, Acute Care
Tax Status: Nonprofit
Professional Staff: 64
Non-Professional Staff: 53
Number of Medical Centers: 2
Total Beds: 430
Average Daily Census: 277
Site Special Features:   Children’s Minnesota is one of the largest independent pediatric health systems in the US, providing care exclusively to children.  An award-winning health system, Children’s is regularly ranked by U.S. News & World Report as a top children’s hospital and by the Leapfrog Group for quality and efficiency. Functionality of the Children’s EHR allows for full implementation of clinical pharmacogenomics into direct patient care allowing electronic decision support to assist clinicians in providing patient specific treatment.